UCB Pharma Limited

208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Summary of Product Characteristics last updated on the eMC: 28/06/2010
SPC Morphine Sulphate Injection BP 10mg in 1ml, 15mg in 1ml & 30mg in 1ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
Date of revision of text on the SPC:   02-Jun-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

4.4 - Additional wording regarding use in reduced respiratory reserve, eg "conditions including but not restricted to the following"  and sleep apnoea added
Updated on 20/04/2009 and displayed until 28/06/2010
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   01-Jul-2005
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.5 - Addition of 10 ampoule pack.
Updated on 15/09/2005 and displayed until 20/04/2009
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 30/09/2004 and displayed until 15/09/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 23/08/2001 and displayed until 30/09/2004
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
  • SPC Retired pending re-submission

Active Ingredients/Generics

 
   morphine sulphate